CSE Bulletin: Consolidation - PanGenomic Health Inc. (NARA)

Toronto, Ontario--(Newsfile Corp. - Le 19 mars/March 2024) - PanGenomic Health Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every ten (10) pre-consolidated common shares.

As a result, the outstanding shares of the company will be reduced to approximately 10,496,746 common shares.

The name and symbol will not change.

Please note that all open orders will be canceled at the close of business on March 20, 2024. Dealers are reminded to re-enter their orders taking into account the share consolidation.

_________________________________

PanGenomic Health Inc. a annoncé une consolidation de ses actions ordinaires émises et en circulation sur la base d'une (1) action ordinaire post-consolidée pour dix (10) actions ordinaires pré-consolidées.

En conséquence, les actions en circulation de la société seront réduites à environ 10 496 746 actions ordinaires.

Le nom et le symbole ne changeront pas.

Veuillez noter que toutes les commandes ouvertes seront annulées à la fermeture des bureaux le 20 mars 2024. Il est rappelé aux concessionnaires de ré-saisir leurs commandes en tenant compte de la consolidation des actions.

If you have any questions or require further information please contact Listings at (416) 367-7340 or E-mail:[email protected].

Pour toute question ou information complémentaire, veuillez contacter Listings au 416 367-7340 ou par courriel à:[email protected].

You May Also Be Interested In

• Yorkton Equity Group Inc. Announces Amendment to Terms of Share Purchase Agreement Previously Announced on July 2, 2026
• Honey Badger SEO Releases New Study on AI Search Citations Across 22 U.S. Markets
• Dr. Donna Pontoriero Launches Dr. Donna Institute, Bringing 30+ Years of Real-World Health and Wellness Experience to a New Education Platform